/301211.SZ

301211.SZ Stock - Hubei Biocause Heilen Pharmaceutical Co., Ltd.

Q: What is the analyst price target for 301211.SZ?

Analyst price target information is not currently available for 301211.SZ.

Q: What is 301211.SZ's market cap?

Market capitalization information is not currently available for 301211.SZ.

Basic Materials|Chemicals|SHZ

$12.55+0.40%

+$0.05 (+0.40%) • Dec 25

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $13.81

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for 301211.SZ

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.88

52W High$17.14

52W Low$9.38

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$445.86M	$663.03M	$514.91M	$540.62M	$592.92M
Gross Profit	$128.59M	$266.35M	$148.69M	$182.30M	$294.38M
Gross Margin	28.8%	40.2%	28.9%	33.7%	49.6%
Operating Income	$100.88M	$205.33M	$148.73M	$139.29M	$198.96M
Net Income	$91.55M	$176.12M	$125.79M	$121.65M	$168.07M
Net Margin	20.5%	26.6%	24.4%	22.5%	28.3%
EPS	$0.32	$0.61	$0.44	$0.42	$0.58

Company Overview

Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China. It provides APIs and intermediates, and formulations; and dimethyl ether gas and chloropropionyl chloride chemical products. The company is based in Jingmen, China.

Visit Website

Frequently Asked Questions about 301211.SZ

What is 301211.SZ's current stock price?

Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211.SZ) is currently trading at $12.55 per share. The stock has moved +0.40% today.

What is the analyst price target for 301211.SZ?

No analyst price targets are currently available for this stock.

What sector is Hubei Biocause Heilen Pharmaceutical Co., Ltd. in?

Hubei Biocause Heilen Pharmaceutical Co., Ltd. operates in the Basic Materials sector, specifically within the Chemicals industry. The company is traded on the SHZ exchange.

What is 301211.SZ's market cap?

Hubei Biocause Heilen Pharmaceutical Co., Ltd. has a market capitalization of $3.61 billion, making it a mid-cap company.

Does 301211.SZ pay dividends?

No, Hubei Biocause Heilen Pharmaceutical Co., Ltd. does not currently pay a dividend to shareholders.